FDA Approval Collides With Patent Law

Introduction: The recent (August 5, 2021) Federal Circuit decision of GSK v Teva, finding Teva induced infringement of a GSK patent, has created a conundrum in the drug patent world.  The facts are a little bit complicated.  However it is interesting to see the Government trip over itself through contradictory regulations.  The following is useful…

Read More →